Rowann Bowcutt
UCB Pharma (United Kingdom)(GB)
Publications by Year
Research Areas
Gut microbiota and health, Parasites and Host Interactions, IL-33, ST2, and ILC Pathways, Clostridium difficile and Clostridium perfringens research, T-cell and B-cell Immunology
Most-Cited Works
- → Helminth infection promotes colonization resistance via type 2 immunity(2016)437 cited
- → Bacterial Sensor Nod2 Prevents Inflammation of the Small Intestine by Restricting the Expansion of the Commensal Bacteroides vulgatus(2014)268 cited
- → Rapid environmental effects on gut nematode susceptibility in rewilded mice(2018)129 cited
- → Heterogeneity across the murine small and large intestine(2014)86 cited
- → Integrated Analysis of Biopsies from Inflammatory Bowel Disease Patients Identifies SAA1 as a Link Between Mucosal Microbes with TH17 and TH22 Cells(2017)40 cited
- → Arginase‐1‐expressing macrophages are dispensable for resistance to infection with the gastrointestinal helminth Trichuris muris(2011)39 cited
- → A role for the pattern recognition receptor Nod2 in promoting recruitment of CD103+ dendritic cells to the colon in response to Trichuris muris infection(2014)31 cited
- → Interleukin 17A and IL-17F Expression and Functional Responses in Rheumatoid Arthritis and Peripheral Spondyloarthritis(2020)19 cited
- → Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon(2015)19 cited
- → Amelioration of Fibrotic Remodeling of Human 3‐Dimensional Full‐Thickness Skin by Transglutamase 2 Inhibition(2023)11 cited